News

New study found that increasing secukinumab dosage to 300 mg provides no significant benefit for ankylosing spondylitis patients who did not respond to 150 mg.

Inherited BRCA mutations may sharply increase the risk of early-onset multiple myeloma, according to new research.

Cannabis and hallucinogen use among adults continued to reach historic highs in 2023, according to the latest findings from the NIH-supported Monitoring the Future (MTF) survey.

Researchers from the University of Cincinnati, Ohio, suggest that increasing levels of the brain protein amyloid-β 42 may slow cognitive decline in Alzheimer’s disease.

Approval has been granted by the FDA for lebrikizumab-lbkz in treating moderate to severe atopic dermatitis in patients aged 12 and older.

Protective cells can be converted into tumor promoters after the immune system has been hijacked by cancer.

Researchers have uncovered a critical mechanism behind why certain viral infections, such as COVID-19, lead to lasting lung damage.

Emerging research has linked COVID-19 to joint pain and osteoarthritis, but the precise mechanisms behind this connection and the damage to articular cartilage were previously unclear.